Global Industrial (NYSE:GIC – Get Free Report) and Capstone Therapeutics (NASDAQ:CAPS – Get Free Report) are both small-cap industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk.
Risk and Volatility
Global Industrial has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, Capstone Therapeutics has a beta of -1.5, suggesting that its stock price is 250% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent ratings and price targets for Global Industrial and Capstone Therapeutics, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Global Industrial | 0 | 3 | 0 | 0 | 2.00 |
| Capstone Therapeutics | 1 | 0 | 0 | 0 | 1.00 |
Global Industrial currently has a consensus price target of $39.00, suggesting a potential downside of 11.61%. Given Global Industrial’s stronger consensus rating and higher possible upside, equities analysts plainly believe Global Industrial is more favorable than Capstone Therapeutics.
Earnings and Valuation
This table compares Global Industrial and Capstone Therapeutics”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Global Industrial | $1.38 billion | 1.22 | $72.10 million | $2.24 | 19.70 |
| Capstone Therapeutics | $60.25 million | 0.03 | -$21.23 million | ($3.35) | -0.03 |
Global Industrial has higher revenue and earnings than Capstone Therapeutics. Capstone Therapeutics is trading at a lower price-to-earnings ratio than Global Industrial, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
31.2% of Global Industrial shares are owned by institutional investors. Comparatively, 2.5% of Capstone Therapeutics shares are owned by institutional investors. 64.5% of Global Industrial shares are owned by insiders. Comparatively, 39.3% of Capstone Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares Global Industrial and Capstone Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Global Industrial | 6.06% | 21.49% | 11.60% |
| Capstone Therapeutics | -36.51% | -144.43% | -40.48% |
Summary
Global Industrial beats Capstone Therapeutics on 13 of the 13 factors compared between the two stocks.
About Global Industrial
Global Industrial Company operates as an industrial distributor of various industrial and maintenance, repair, and operation (MRO) products in North America. It offers storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, foodservice and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials. The company offers industrial and MRO products under the Global, GlobalIndustrial.com, Nexel, Paramount, Interion, and Absocold trademarks. It serves businesses; state, local, and private educational organizations; and government entities through relationship marketers, e-commerce sites, signature campaigns, and catalogs. The company was formerly known as Systemax Inc. Global Industrial Company was founded in 1949 and is headquartered in Port Washington, New York.
About Capstone Therapeutics
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
Receive News & Ratings for Global Industrial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Industrial and related companies with MarketBeat.com's FREE daily email newsletter.
